Neurocrine Biosciences (NBIX) Tops Q2 EPS by 10c
Tweet
Share
E-mail
Get Alerts NBIX Hot Sheet
Price: $146.23 --0%
Revenue Growth %: +30.8%
Financial Fact:
Research and development: 20.94M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Revenue Growth %: +30.8%
Financial Fact:
Research and development: 20.94M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q2 EPS of ($0.07), $0.10 better than the analyst estimate of ($0.17).
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- JPMorgan Downgrades Shanghai Chicmax Cosmetic (2145:HK) to Neutral
- BTIG Reiterates Top Pick on Atlassian Corporation (TEAM)
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
